| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/14/2003 | US6506564 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/14/2003 | US6506563 Multiparametric fluorescence in situ hybridization |
| 01/14/2003 | US6506562 Allele frequency differences method for phenotype cloning |
| 01/14/2003 | US6506561 Method of obtaining a library of tags capable of defining a specific state of a biological sample |
| 01/14/2003 | US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 01/14/2003 | US6506559 Molecular hybridization of complementary strands |
| 01/14/2003 | US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide |
| 01/14/2003 | CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof |
| 01/13/2003 | CA2393376A1 Assay methods |
| 01/13/2003 | CA2353183A1 Fractionation apparatus with low surface area grid above tray deck |
| 01/09/2003 | WO2003003277A2 High-efficiency microarray printing device |
| 01/09/2003 | WO2003003057A2 System and method for capturing multi-color fish images |
| 01/09/2003 | WO2003003018A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/09/2003 | WO2003003016A1 Diagnostic methods and agents |
| 01/09/2003 | WO2003003015A2 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 01/09/2003 | WO2003003014A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003003006A2 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |
| 01/09/2003 | WO2003003001A1 Electrochemical detection of analytes |
| 01/09/2003 | WO2003002979A2 Multiplex decoding of array sensors with microspheres |
| 01/09/2003 | WO2003002976A2 Methods and reagents for detecting endotoxin |
| 01/09/2003 | WO2003002975A2 Biophotonic sensors and methods of use thereof |
| 01/09/2003 | WO2003002767A1 Method of dna sequencing using cleavable tags |
| 01/09/2003 | WO2003002766A2 Method for detection of foot-and-mouth disease virus |
| 01/09/2003 | WO2003002765A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/09/2003 | WO2003002764A2 Screening method for identifying cancer therapy-relevant compounds |
| 01/09/2003 | WO2003002763A1 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 01/09/2003 | WO2003002762A2 Enhanced detection and distinction of differential gene expression by enzymatic probe ligation and amplification |
| 01/09/2003 | WO2003002760A2 Method for detecting cytosine methylation by comparatively analysing single strands of amplificates |
| 01/09/2003 | WO2003002759A2 Detection of specific dinucleotides in dna-samples by fluorescence resonance energy transfer (fret) |
| 01/09/2003 | WO2003002757A1 Method for kidney disease detection by protein profiling |
| 01/09/2003 | WO2003002756A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 01/09/2003 | WO2003002755A2 Glaucoma treatments with reduced hyperpigmentation |
| 01/09/2003 | WO2003002753A2 Diagnostic assays for parvovirus b19 |
| 01/09/2003 | WO2003002752A2 Methods of using nick translate libraries for snp analysis |
| 01/09/2003 | WO2003002750A2 High throughput assay system |
| 01/09/2003 | WO2003002748A2 Detection of microbiological contaminants in samples of non-living material |
| 01/09/2003 | WO2003002746A2 Perv screening method and use thereof |
| 01/09/2003 | WO2003002742A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | WO2003002733A2 Compositions for enhanced catalyzed reporter deposition |
| 01/09/2003 | WO2003002732A1 Citrate lyase poly peptides |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002721A2 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | WO2003002716A2 Polymer stabilized proteinases |
| 01/09/2003 | WO2003002712A2 Gene expression alterations underlying the retardation of aging by caloric restriction in mammals |
| 01/09/2003 | WO2003002711A2 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 01/09/2003 | WO2003002709A2 Novel technology for genetic mapping |
| 01/09/2003 | WO2003002633A1 Synthesis and use of organosilica particles |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002589A1 Diagnostics and therapeutics for autosomal dominant hemochromatosis |
| 01/09/2003 | WO2003002528A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002114A2 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 01/09/2003 | WO2003002068A2 Diagnosis and treatment of cancer |
| 01/09/2003 | WO2003002065A2 Hcv e1e2 vaccine compositions |
| 01/09/2003 | WO2003001985A2 Method for detection of melanoma |
| 01/09/2003 | WO2003001983A2 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function |
| 01/09/2003 | WO2003001976A2 A secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 01/09/2003 | WO2003001968A2 Compositions and methods for inhibiting platelet activation and thrombosis |
| 01/09/2003 | WO2003001881A2 Cell-based high-throughput screening methods |
| 01/09/2003 | WO2003001877A2 Methods for the diagnosis and treatment of cardiac tissue rejection |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |
| 01/09/2003 | WO2002079786A9 Method for identifying drugs for the treatment of type ii diabetes |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002059558A3 Means and methods for treatment evaluation |
| 01/09/2003 | WO2002056923A3 Indicator systems for determination of sterilization |
| 01/09/2003 | WO2002048387A3 System and method for predicting chromosomal regions that control phenotypic traits |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002037112A3 Detection of ovarian cancer |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002018648A3 Analysis of binding interactions |
| 01/09/2003 | WO2002016655A9 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2002012885A3 Simple methods for the drug monitoring of gpiib/iiia-receptor antagonists |
| 01/09/2003 | WO2002012566A3 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 01/09/2003 | WO2002004670A3 Improved capture and detection of target nucleic acid in dipstick assays |
| 01/09/2003 | WO2002002766A3 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/09/2003 | WO2002000618A3 Progesterone receptor-regulated gene expression and methods related thereto |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001094924A3 Method for analysing enzyme-catalysed reactions using maldi-tof mass spectrometry |
| 01/09/2003 | WO2001092463A3 Method of rna cleavage |
| 01/09/2003 | WO2001075173A3 β 2 ADRENERGIC POLYMORPHISM DETECTION |
| 01/09/2003 | WO2001075163A3 High throughput methods for haplotyping |
| 01/09/2003 | WO2001073127A3 Improved invasion assay |
| 01/09/2003 | WO2001070776A3 Nimr compositions and their methods of use |
| 01/09/2003 | WO2001066801A3 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 01/09/2003 | WO2001062952A9 Methods for determining single nucleotide variations |
| 01/09/2003 | WO2001057278A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 01/09/2003 | WO2001057276A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001053817A9 Methods of and apparatus for separating and detecting nucleic acid |